Dr. Wade Michael Smith, MD

Dr. Smith practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Smith's NPI, 1730240219, was assigned on December 12, 2006. Dr. Smith graduated from Creighton University School of Medicine - Omaha in 1999. Dr. Smith's California license number on file is A93190.

Dr. Smith's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (626) 256-4673.

Dr. Smith's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Smith is also affiliated with Hoag Hospital Newport Beach. The medical group on file is City of Hope. Dmand AI also links Dr. Smith to 1 more hospital, 1 group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Smith is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Smith's licenses on file in 2 states: California and Georgia.

Dmand AI lists breast cancer, chronic anemia, lung cancer, lymphoma, multiple myeloma, neutropenia, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Smith treats.

CMS data shows 83,568 Medicare services from Dr. Smith across 41 procedure codes in 2024, for 485 Medicare patients. Medicare paid $1,486,911 for them.

CMS counts 485 Medicare patients who saw Dr. Smith in 2024. The largest group is 65 to 74, with 219 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 67, with 80% women.

In 2024, Dr. Smith wrote 342 Medicare Part D claims for 94 patients. 77% of them were for generic drugs. CMS names the drug for 180 of them, across 7 drugs with 11 or more claims each, at $210,583 in total drug cost. In 2023, CMS named 98 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Smith for performance year 2024, reported as part of a group. Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Smith as offering telehealth.

Dmand AI links 3 papers to Dr. Smith in 2020. Dr. Smith's most frequent co-authors are Mary Cianfrocca, DO, Laura Kruper, MD and Sayeh Moazami Lavasani, MD.

CMS Open Payments shows 129 general payments to Dr. Smith from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Novartis Pharmaceuticals Corporation paid the most, $3,780.

Dr. Smith graduated from Creighton University School of Medicine - Omaha in 1999.

Dr. Smith is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.